How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Identification of Co-Circulating Dengue and South America–Origin Zika Viruses, Pakistan, 2021–2022 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – ACE2 Receptor Usage across Animal Species by SARS-CoV-2 Variants – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Nipah Virus Antibodies in Bats, the Philippines, 2013–2022 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Community-Scale Surveillance of SARS-CoV-2 and Influenza A Viruses in Wild Mammals, United States, 2022–2023 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Isolation of Highly Pathogenic Avian Influenza A(H5N1) Virus from Cat Urine after Raw Milk Ingestion, United States – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – COVID-19 Predeparture Test Results and Vaccination Coverage among US-Bound Refugees, 2020–2022 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Multidisciplinary Tracking of Highly Pathogenic Avian Influenza A(H5N1) Outbreak in Griffon Vultures, Southern Europe, 2022 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Crimean-Congo Hemorrhagic Fever Virus among Goats, Southern Bhutan – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Genomic Surveillance Detection of SARS-CoV-1–Like Viruses in Rhinolophidae Bats, Bandarban Region, Bangladesh – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Group A Streptococcus among American Indian Persons, White Mountain Apache Tribal Lands, United States, 2016–2019 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us